Dr Steven John Allder B.Med.Sci, BMBS, FRCP, DM GMC Registration: 4019983
Personal Profile Certified Consultant Neurologist, who has worked in general neurology clinics that included headache, assessment of epilepsy, Parkinson s disease and related movement disorders, and neuromuscular disease; An established sub-specialist interest in acute brain injury, cerebrovascular disease, dizziness and medically unexplained symptoms; Currently establishing ground breaking clinics in the assessment of traumatic brain injury and medically unexplained neurological symptoms; Proven track record in clinical research, as well as being an experienced and enthusiastic teacher and trainer; Training in Clinical Systems Engineering (CSE) via the national OSPREY programme, with a history of engaging with changes in the NHS environment and utilising management skills to deliver clinically driven change; Recognised in Top 50 clinical innovators in the NHS by the Health Service Journal; Seven years experience of working in a range of senior medical management roles, including a recent tenure as Assistant Medical Director of Plymouth Hospitals NHS Trust; Graduate of Harvard Kennedy Business School; APIL Tier 1 medico-legal expert in the field of neurology and member of award winning Re:Cognition Health medico-legal team. Qualifications Qualification Awarding Body Year Obtained Doctor of Medicine University of Nottingham 2003 Membership of the Royal Colleges of London College 1996 Physicians (MRCP) Bachelor of Medicine University of Nottingham 1993 Bachelor of Medical Science University of Nottingham 1991 Employment History Current position Accountable to: May August 2015: Accountable to: Consultant Neurologist Re:Cognition Health, 45 Queen Anne Street, London W1G 9JF Focusing clinically on traumatic brain injury and medically unexplained symptoms Director of Operations Locum Consultant Neurologist Hampshire Hospitals NHS Foundation Trust Clinical Director 2010 August 2013 Assistant Medical Director Accountable to: Medical Director 2010 December 2012 Clinical Director of NHS Plymouth Stroke Service Line Accountable to: Chief Executive of NHS Plymouth (Plymouth Primary Care Trust) 2009 June 2010 Lead for Clinical Safer Systems Programme (in partnership with The Health Foundation Accountable to: Medical Director 2007 December 2009 Head of Clinical Systems Engineering (CSE) Plymouth Hospitals NHS Trust Accountable to: Medical Director Operations
2005 2008 Clinical Director for Neurosciences and Ophthalmology (incorporating Neurology, Neurosurgery, Neurophysiology, Neuropsychology and a stand alone Ophthalmology service) Plymouth Hospitals NHS Trust Accountable to: Chief Operating Officer January 2004 March 2015 Consultant Neurologist Plymouth Hospitals NHS Trust Accountable to: Service Line Director Key Achievements and learning: Continued to develop sub-specialist interest in Cerebrovascular disease; Established a joint Neurology-ENT clinic to investigate and treat dizziness ; Invited to join a national network focussing on Medically Unexplained Symptoms; Developed a sub-specialist interest in the physiological substrates of back pain; Recognised expert in critical incident analysis. January 2001 January 2004 July 2000 July 2001 August 1997 January 2000 Specialist Registrar Royal Hallamshire Hospital, Sheffield Clinical Fellowship Liverpool Hospital, Sydney, Australia Research Fellow Department of Neurology, Nottingham University Medico-legal Experience Instructions Sub-type Personal injury Head injury Electrocution Loss of memory Medical negligence All related to acute stroke Condition and prognosis Post stroke Post head injury Post assault Criminal All successfully defended Dissociated state (2) Confusional Arousal Cerebral Lupus Epileptic amnesia This work has also given me several important additional insights, which make the work genuinely interesting and rewarding professionally: There is great need for more precision of conditions in medicine; I have re-engaged with the true consequences of head injury. During my fellowship in Sydney Australia, I worked with head injury patients in a managed network. This was very valuable but is very lacking in the NHS; The thoroughness required consistently reveals important nuances that are critical for diagnosis and prognosis, and this re-invigorated my NHS practice; I have been surprised how my two other sub-specialties have been represented: Dizziness Medically unexplained symptoms this area is particularly poorly served
Finally, it is now clear that the medico-legal avenue could be a very powerful way to pursue my passion for service design. Research Experience 2002-2003 Evaluation of the clinical efficiency and cost effectiveness of alternative pathways of care for patients with TIA Departments of Clinical Neurology, ScHARR, and Vascular Institute. M. Stevenson, S Allder, G Venables, P Rothwell, S Thomas. Funding: Wellcome Trust, 100,000 2001-2003 Clinical utility of FDG-18 PET scanning inpatients with unexplained progressive neurological syndromes Departments of Clinical Neurology, Academic Radiology, and Medical Physics. Nottingham University. S Allder, M Hadjivassilou, B Sharrack, M Hanney, W Tindell, E Van Beek Funding: Sheffield Teaching Hospitals Charitable Trust, 50,000 1998-2000 Direct Thrombus Imaging in carotid stenosis Departments of Clinical Neurology, Academic Radiology, Pathology and Vascular Surgery. Nottingham University. S Allder, R Murphy A, Moody, A Martel. P Morgan, J Gladman, J Lowe, S McSweeney, B Hunt. Funding: Stroke Association Project Grant (1998-2001) 100,000 and Stroke Association Project Grant (2001-2004) 100,000 1997-2000 Multi-Modal MRI study of acute ischaemic stroke Departments of Clinical Neurology and Academic Radiology. Nottingham University. S Allder, A Moody, A Martel. P Morgan, J Gladman, G Lennox Funding: Stroke Association Fellowship 25,000 and Stanhope Neurological Fellowship 80,000
Management Papers and Presentations: Publications and Presentations Allder, S., Silvester, K., and Walley, P., Is follow up capacity the current NHS bottleneck? Clinical Medicine, The Journal of the Royal College of Physicians (in press April 2011) Allder, S., Silvester, K., and Walley, P., Understanding the current state of patient flow in a hospital, Clinical Medicine, The Journal of the Royal College of Physicians; Volume 10, Number 5, October 2010, pp 441-4 Allder, S., Sylvester, K., Walley, P., Managing capacity and demand across the patient pathway, Clinical Medicine, The Journal of the Royal College of Physicians; Volume 10, Number 1, February 2010, pp 13-15 (3) Allder, S., Finance on the front line, Public Service, Tuesday 29 July 2008 see link for details - Finance on the front line Allder, S., Taking the Lead, Public Service Review: Health, Issue 17, Friday 24 October 2008 see link for details - Taking the lead A practical guide to developing your skills as an Effective Clinical Director, BAMM and Healthcare Events Joint Conference (2009); HSC Safety Forum Breakfast Seminar, Northern Ireland Health Executive (2009); INNoV'08 Conference, Keynote Speech and Workshop Lead, New Zealand Ministry of Health (2008); Why do we need so many beds?, Joint Conference with the NHS Confederation and Royal College of Physicians (2008); World Class Commissioning for Neurosciences, Joint Working Group Annual Meeting, Society of British Neurological Surgeons (2008); AAGBI Annual Congress (2008) Patient Involvement, Empowerment and Information Healthcare Events (2007) Clinical Papers and Presentations: Allder, S and Mukonoweshuro, P., Cerebrovascular disease. ACNR. 2005; Jul 20-23. Allder S, Moody A, Martel A, Gladman J, Lennox G., Differences in diagnostic accuracy of clinical subtypes defined by Multi-Modal MRI in acute stroke. JNNP. 2003; 74. 7.868-870. R Murphy, AR Moody, PS Morgan, AR Martel, GS Delay, SJ Allder, S MacSweeney, WG Tennant, J Gladman, J Lowe, B Hunt., The Prevalence of complicated carotid atheroma as detected by Magnetic Resonance Direct Thrombus Imaging (MRDTI) in patients with suspected carotid artery stenosis and previous acute cerebral ischaemia. Circulation. 2003 Jun 24; 107 (24): 3053-8. AR Moody, R Murphy, PS Morgan, AR Martel, GS Delay, SJ Allder, S MacSweeney, WG Tennant, J Gladman, J Lowe, B Hunt., Characterisation of complicated carotid plaque with magnetic resonance direct thrombus imaging (MRDTI) in patients with cerebral ischaemia. Circulation. 2003 Jun 24; 107 (24): 3047-52. Winter M, Allder S, Sharrack B, Makris M., Lack of classical thrombophilic risk factors in cerebral venous thrombosis. Blood 2003; 103; suppl 1 pt 2: page 115b Moody, A.R., et al., Contrast-reduced imaging of tissue concentration and arterial level (CRITICAL) for assessment of cerebral hemodynamics in acute stroke by magnetic resonance. Invest Radiol, 2000. 35(7): p. 401-11
Martel A, Allder S, Moody A, Gladman J, Lennox G., Extracting parametric images from dynamic contrast-enhanced MRI studies of the brain using factor analysis. Med Image Anal. 2001 Mar; 5(1):29-39. Martel A, Allder S, Moody A, Gladman J, Lennox G., Perfusion MRI of infarcted and noninfarcted brain tissue in stroke: a comparison of conventional hemodynamic imaging and factor analysis of dynamic studies. Invest Radiol, 2001. 36(7): p. 378-85. Stone S, Allder S, Gladman J., Predicting outcome in Stroke: What should I tell my patients? Br. Med Bull. 2000; 56 (2): 486-94. Allder S, Moody A, Martel A, Gladman J, Lennox G., Limitations of clinical diagnosis in acute stroke. Lancet. 1999. 354. 1523. Moody A, Allder S Gladman J, Lennox G, Fentem P., Direct Magnetic Resonance Imaging of Carotid Thrombus in Acute Stroke. Lancet 1999; 353:3:122-3. Martel A, Allder S, Moody A, Gladman J, Lennox G., Measurement of Infarct Volume in Stroke Patients Using Adaptive Segmentation of DWI MR images. MICCAI 99. Springer Verlag. Allder S, Moody A, Martel A, Gladman J, Lennox G., Focal cerebral hyperperfusion demonstrated by perfusion MRI during migraine with hemiparesis. JNNP 1999: 66(2):268. Meeting of Association of British Neurologists (ABN), 2003. Clinical utility of FDG-18 PET scanning in-patients with unexplained progressive neurological syndromes. 5 th European Epilepsy Conference (Madrid), 2002. Initial experience of Keppra in routine clinical practice in patients with refractory epilepsy. Australian Neurological Association Conference, 2001. Correlation of clinical deficit with MMMRI in the acute phase of stroke. Meeting of ABN, 2000. Serial MMMRI following middle cerebral artery occlusion. European Stroke Conference (Vienna), 2000: Perfusion MRI of infarcted and noninfarcted brain tissue in stroke: a comparison of conventional hemodynamic imaging and factor analysis of dynamic studies. Imaging Leptomeningeal collateral supply with MRI. Predicting outcome from acute stroke with MMMRI. American Neurological Association (Seattle, 1999. Limitations of clinical diagnosis in acute stroke. Lancet Stroke Conference (Montreal), 1998. Can Multi-modal MRI (MMMRI) Define the Penumbra? EFNS (Seville), 1998. Magnetic Resonance Imaging to characterise symptomatic carotid stenosis. Meeting of ABN, 1998. Predicting Acute Clinical Outcome of Stroke using Multimodal (MM) MRI. British Geriatric Society, 1998. Extending the therapeutic window of stroke? References References are available on request.